However, we cannot talk about advancing healthcare innovation without addressing the harmful drug pricing provision the Democrats' reckless tax and spending spree bill that will ultimately restrict patients' access to timely care and lead to less cures.
Guthrie criticizes Democratic drug pricing policies affecting healthcare access.
Share & report
More from James Guthrie
It is unfortunate that the Department of Defense--the Department of Justice can't be here today to explain this policy.
I support the bipartisan alternative, Lower Cost and More Cures Act, to reduce drug prices and protect innovative cures.
It is long overdue for Congress to take the necessary step of banning QALYs.
I hope today can be a start on finding bipartisan solutions to make healthcare pricing more transparent.
Other voices in this conversation
